西他赛100毫克注射液

西他赛100毫克注射液 (Citasai 100mg Injection) is a pharmaceutical product containing the active ingredient Siltuximab. Siltuximab is a chimeric monoclonal antibody designed to target and neutralize interleukin-6 (IL-6), a key cytokine involved in inflammation and B-cell proliferation. By binding to IL-6, Siltuximab inhibits its activity, thereby reducing the inflammatory response and the growth of certain types of cancer cells that rely on IL-6 for survival and proliferation.

This medication is indicated for the treatment of specific conditions where IL-6 plays a significant role. It is primarily used in adults with idiopathic multicentric Castleman disease (iMCD) who are treatment-naive or have relapsed after at least one prior therapy. The typical dosage and administration schedule are determined by a healthcare professional based on the patient’s condition and response.

Common side effects associated with Siltuximab treatment may include infusion-related reactions, infections (such as upper respiratory tract infections and pneumonia), and hypersensitivity reactions. Patients should be closely monitored during and after administration for any adverse events. It is crucial to inform your doctor about any pre-existing medical conditions, especially if you have a history of infections or allergies, and any other medications you are currently taking.

西他赛100毫克注射液 should be stored according to the manufacturer’s instructions, typically refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. The injection should be administered by a qualified healthcare professional. Consult your physician or pharmacist for detailed usage instructions and any further information.